Optiver Holding
AKRO

Optiver Holding’s Akero Therapeutics AKRO Stock Holding History

Optiver Holding’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-514
Closed -$24.4K – 2459
2025
Q3 		$24.4K Sell
514
-3
-0.6% -$145 ﹤0.01% 917
2025
Q2 		$27.6K Buy
517
+113
+28% +$5.13K ﹤0.01% 752
2025
Q1 		$16.4K Buy
+404
New +$17.1K ﹤0.01% 760

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Optiver Holding's AKRO Position: Q4 2025 in Review

Optiver Holding sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 514 shares — an estimated $24.4K sold.

Optiver Holding first reported a position in AKRO in Q1 2025 and held it in 3 quarters. The position peaked at $27.6K in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Optiver Holding reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Optiver Holding sold 514 Akero Therapeutics shares in Q4 2025, an estimated $24.4K.
  • Optiver Holding first reported a position in Akero Therapeutics in Q1 2025 and held it in 3 quarters.
  • Optiver Holding's Akero Therapeutics position peaked at $27.6K in Q2 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Optiver Holding's 13F filing for Q4 2025, filed 17 Feb 2026.